Self administration of cocaine in monkeys receiving LAAM acutely or chronically

Physiology and Behavior

Volumn 93, Issue 1-2, 2008, Pages 20-26

  Gerak, Lisa R ^a   Galici, Ruggero ^a,b   France, Charles P ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Cocaine; LAAM; Rhesus monkeys; Self administration

Indexed keywords

ACETYLMETHADOL; COCAINE; NARCOTIC AGENT;

ADDICTION; ANIMAL; ARTICLE; DOSE RESPONSE; DRUG INTERACTION; DRUG SELF ADMINISTRATION; FEMALE; MACACA; MALE; REINFORCEMENT;

ANIMALS; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; MACACA MULATTA; MALE; METHADYL ACETATE; NARCOTICS; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; SUBSTANCE-RELATED DISORDERS;

EID: 42449158197     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2007.07.008     Document Type: Article

References (32)

1. Kreek MJ, Vocci FJ. History and current status of opioid maintenance treatments: blending conference session. J Subst Abuse Treat 2002;23:93-105.
2. Ling W, Rawson RA, Compton MA. Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine. J Psychoact Drugs 1994;26:119-28.
3. Vocci FJ, Acri J, Elkashef A. Medication development for addictive disorders: the state of the science. Am J Psychiatry 2005;162:1432-40.
4. Tennant Jr FS, Rawson RA, Pumphrey E, Seecof R. Clinical experiences with 959 opioid-dependent patients treated with levo-alpha-acetylmethadol (LAAM). J Subst Abuse Treat 1986;3:195-202.
5. Peles E, Schreiber S, Adelson M. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel. Drug Alcohol Depend 2006;82:211-7.
6. Darke S, Swift W, Hall W, Ross M. Drug use, HIV risk-taking and psychosocial correlates of benzodiazepine use among methadone maintenance clients. Drug Alcohol Depend 1993;34:67-70.
7. Lintzeris N, Mitchell TB, Bond A, Nestor L, Strang J. Interactions on mixing diazepam with methadone or buprenorphine in maintenance patients. J Clin Psychopharmacol 2006;26:274-83.
8. Strain EC, Stitzer ML, Liebson IA, Bigelow GE. Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index. J Clin Psychopharmacol 1996;16:58-67.
9. Blaine JD, Renault PR, Thomas DB, Whysner JA. Clinical status of methadyl acetate (LAAM). Ann N Y Acad Sci 1981;362:101-15.
10. Jaffe JH, Senay EC, Schuster CR, Renault PR, Smith B, Dimenza S. Methadyl acetate vs methadone. A double-blind study in heroin users. JAMA 1972;222:437-42.
11. Longshore D, Annon J, Anglin MD, Rawson RA. Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use. Addiction 2005;100:1131-9.
12. Senay EC, Dorus W, Renault PF. Methadyl acetate and methadone. An open comparison. JAMA 1977;237:138-42.
13. Yokel RA. Intravenous self-administration: response rates, the effects of pharmacological challenges, and drug preferences. In: Bozarth ME, editor. Methods of assessing the reinforcing properties of abused drugs. New York: Springer Verlag; 1987. p. 1-33.
14. Schuster CR, Johanson CE. The use of animal models for the study of drug abuse. In: Gibbons RJ, Israel Y, Kalant H, Popham RE, Schmidt W, Smart RG, editors. Recent advances in alcohol and drug problems. New York: Wiley and Sons; 1974. p. 1-31.
15. Mello NK, Negus SS. The effects of buprenorphine on self-administration of cocaine and heroin "speedball" combinations and heroin alone by rhesus monkeys. J Pharmacol Exp Ther 1998;285:444-56.
16. Lukas SE, Moreton JE, Khazan N. Effects of levo-alpha-acetylmethadol (LAAM) on morphine self-administration in the rat. Psychopharmacology 1981;73:12-6.
17. Foltin RW, Fischman MW. Effects of methadone or buprenorphine maintenance on the subjective and reinforcing effects of intravenous cocaine in humans. J Pharmacol Exp Ther 1996;278:1153-64.
18. Negus SS, Mello NK. Effects of chronic methadone treatment on cocaineand food-maintained responding under second-order, progressive-ratio and concurrent-choice schedules in rhesus monkeys. Drug Alcohol Depend 2004;74:297-309.
19. Lukas SE, Mello NK, Drieze JM, Mendelson JH. Buprenorphine-induced alterations of cocaine's reinforcing effects in rhesus monkey: a doseresponse analysis. Drug Alcohol Depend 1995;40:87-98.
20. Mello NK, Lukas SE, Kamien JB, Mendelson JH, Drieze J, Cone EJ. The effects of chronic buprenorphine treatment on cocaine and food self-administration by rhesus monkeys. J Pharmacol Exp Ther 1992;260:1185-93.
21. Winger G, Skjoldager P, Woods JH. Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys. J Pharmacol Exp Ther 1992;261:311-7.
22. Gerak LR, Butelman ER, Woods JH, France CP. Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys. J Pharmacol Exp Ther 1994;271:993-9.
23. Gerak LR, France CP. Discriminative stimulus effects of nalbuphine in rhesus monkeys. J Pharmacol Exp Ther 1996;276:523-31.
24. Winsauer PJ, Moerschbaecher JM. Differential effects of 5-HT agonists and antagonists on the repeated acquisition and performance of response sequences in monkeys. Behav Pharmacol 2000;11:535-53.
25. Wojnicki FH, Bacher JD, Glowa JR. Use of subcutaneous vascular access ports in rhesus monkeys. Lab Anim Sci 1994;44:491-4.
26. Misra AL, Mule SJ, Bloch R, Bates TR. Physiological disposition and biotransformation of l-alpha-[2-3H]acetylmethadol (LAAM) in acutely and chronically treated monkeys. J Pharmacol Exp Ther 1978;206:475-91.
27. Brandt MR, Cabansag SR, France CP. Discriminative stimulus effects of lalpha- acetylmethadol (LAAM), buprenorphine and methadone in morphine- treated rhesus monkeys. J Pharmacol Exp Ther 1997;282:574-84.
28. Killam Jr KF, BroccoMJ, Robinson CA. Evaluation of narcotic and narcotic antagonist interactions in primates. Ann N YAcad Sci 1976;281:331-5.
29. Misra AL, Mule SJ. Severe toxicity and lethality in some monkeys following chronic administration of levo-alpha-acetylmethadol (LAAM). Am J Drug Alcohol Abuse 1977;4:431-40.
30. Best D, Gossop M, Stewart D, Marsden J, Lehmann P, Strang J. Continued heroin use duringmethadone treatment: relationships between frequency of use and reasons reported for heroin use. Drug Alcohol Depend 1999;53:191-5.
31. Winger G, Woods JH. The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys. Drug Alcohol Depend 2001;62:181-9.
32. Krantz MJ, Lewkowiez L, Hays H, Woodroffe MA, Robertson AD, Mehler PS. Torsade de pointes associated with very-high-dose methadone. Ann Intern Med 2002;137:501-4.